Patient information centre
+ 1 646 88 33 419 (USA)
+ 44 20 38 684 002 (UK)


Oncolytic virotherapy is an effective cancer treatment using a special virus, which is capable of finding and destroying cells of a malignant tumour in the body. The medication is injected directly into the muscle of the patient. Virotherapy usually takes place on an out-patient basis pursuant to a tailor-made treatment protocol and in accordance with the application of treatment guidelines. The average treatment period is 3 years during which a regular monitoring of analyses and patient observation takes place.

Cancer virotherapy is a treatment method that is gentle to the body and has few side effects. The most common side effect is a slightly increased body temperature (up to 37.50C) lasting one to three days.

Treatment process

  • The patient contacts the IVC Information Center or a doctor specialising in virotherapy.

  • The patient makes the necessary analyses and sends the results to the doctor.

  • After reading the patient's medical history and analyses, the doctor provides a recommendation regarding the possibility of using virotherapy.

  • If virotherapy is an option, an individual treatment schedule is created matching the patient's type of cancer, localisation, tumour stage and the condition of their immune system.

  • The course of virotherapy treatment is administered – a patient receives their first injections of the medication.

  • The frequency of injections usually decreases over the course of the treatment.

  • Regular monitoring of analyses and patient observation takes place.

  • The treatment schedule can be corrected depending on the results of the analyses.


Oncolytic Virotherapy with the Riga Virus is available worldwide. If you’d like to find out more about the possibilities of virotherapy treatment, to find the closest virotherapy delivery location, to learn more about the treatment process or other related issues, please contact the Patient Information Center.

← Go back

Application form

Teatra 9-9, Riga,
LV-1050, Latvia

+ 44 20 38 684 002 (UK, London)
+ 1 646 88 33 419 (USA, New York)
+ 371 67 229 599 (Latvia)